Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Taiyuan Zhang, Yingying Wu, Zhipeng Cheng, Ao Zhang, Lin Liu, Lu Zhang, Danying Liao, Wei Xie, Fang Liu, Guohui Cui, Yu Hu, Heng Mei, Jun Fang

Blood (2025) 146 (Supplement 1): 7207.

https://doi.org/10.1182/blood-2025-7207

Published: 2025

Journal Articles

Mitoxantrone hydrochloride liposome-based CMOP±R regimen achieves superior response in treatment-Naïve non-Hodgkin lymphoma: A phase III clinical trial with matching-adjusted indirect comparison

Tao You, Jin Zhou, Yun Wang, Chenwen Wang, Qian Wang, Xiao Ma, Peng Xu, Yuhu Feng, Jun Fang, Miao Zheng, Depei Wu, Haiwen Huang

Blood (2025) 146 (Supplement 1): 1924.

https://doi.org/10.1182/blood-2025-1924

Published: 2025

Journal Articles

A retrospective study on orelabrutinib combined with anti-CD20 monoclonal antibody regimen in treating mucosa-associated lymphoid tissue lymphoma.

Hongyong Zhang, Zhipeng Cheng, Yingying Wu, Chunyan Sun, Danying Liao, Guohui Cui, Linghui Xia, Yu Hu, Heng Mei, Jun Fang

Blood (2025) 146 (Supplement 1): 7130.

https://doi.org/10.1182/blood-2025-7130

Published: 2025

Journal Articles

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Blood (2025) 146 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2025-1878

Published: 2025

Journal Articles

A Retrospective Analysis of the Efficacy and Safety of Orelabrutinib-Containing Regimens in Marginal Zone Lymphoma

Hongyong Zhang, Zhipeng Cheng, Heng Mei, Chunyan Sun, Yingying Wu, Danying Liao, Fei Zhao, Yu Hu, Linghui Xia, Jun Fang

Blood (2024) 144 (Supplement 1): 6282.

https://doi.org/10.1182/blood-2024-198795

Published: 2024

Journal Articles

A Retrospective Analysis of Efficacy and Safety of Orelabrutinib Maintenance in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Zhiming Li, Jun Fang, Huilai Zhang, Wei Wang, Hui Li, Hui Zhou, Liqun Zou, Hong Cen, Wen Shujuan, Wuping Li, Peng Sun, Panpan LIU, Hang Yang, Yu Wang

Blood (2024) 144 (Supplement 1): 6542.

https://doi.org/10.1182/blood-2024-204292

Published: 2024

Journal Articles

A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma

Yingying Wu, Ao Zhang, Liling Zhang, Guohui Cui, Fang Liu, Zhichao Chen, Zhipeng Chen, Lu Zhang, Lin Liu, Wenjuan He, Yu Hu, Linghui Xia, Jun Fang

Blood (2024) 144 (Supplement 1): 6501.

https://doi.org/10.1182/blood-2024-202483

Published: 2024

Journal Articles

Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

Blood (2024) 144 (Supplement 1): 4855.

https://doi.org/10.1182/blood-2024-202870

Published: 2024

Journal Articles

Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx TM Hyperplexed Immunofluorescence Assay in Hodgkin Lymphoma

Qingyan Au, PhD, Jun Fang, PhD, Anna Juncker-Jensen, PhD, Judy Kuo, Eric Leones, Flora Sahafi, RaghavKrishna Padmanabhan, PhD, Nicholas Hoe, PhD, Josette William, MD, PhD

Blood (2018) 132 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2018-99-115434

Published: 2018

Journal Articles

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Jing Pan, MD, Tong Wu, MD, Jun-Fang Yang, MD, Jian-Ping Zhang, Yan-Li Zhao, Yang Zhang, MD, Hong-Xing Liu, MD, Chun-Rong Tong, MD

Blood (2016) 128 (22): 3985.

https://doi.org/10.1182/blood.V128.22.3985.3985

Published: 2016

Journal Articles

Deguelin Induced Differentiation of NPM1-Mutant AML In Vivo and in Vitro

Xia Zhang, MD PhD, Zichu Zhao, MD PhD, Sha Yi, MD PhD, Lu Wen, MD PhD, Jing He, MD PhD, Jingyu Hu, MD PhD, Jun Ruan, MD PhD, Jun Fang, MD PhD, Yan Chen, MD PhD

Blood (2016) 128 (22): 4030.

https://doi.org/10.1182/blood.V128.22.4030.4030

Published: 2016

Journal Articles

SRC-3 Ubiquination, Mediated By Cullin3, Potentiates Gambogic Acid-Induced Apoptosis in Non-Hodgkin's Lymphoma

Zichu Zhao, Lu Wen, Sha Yi, Xia Zhang, Jingyu Hu, Jun Ruan, Fei Zhao, Guohui Cui, Jun Fang, Yan Chen

Blood (2015) 126 (23): 4854.

https://doi.org/10.1182/blood.V126.23.4854.4854

Published: 2015

Journal Articles

Low-Dose Deguelin, Selective Targeting of Mt NPM1, Induces Differentiation in NPMc+ AML Cells By Regulation the Axis of SIRT1/CEBPβ/G-CSFR, Instead of HDAC1/3

Youping Wang, Zichu Zhao, Jingyu Hu, Fei Zhao, Jing He, Jun Fang, Chun Zhang, Guohui Cui, Yan Chen

Blood (2014) 124 (21): 2231.

https://doi.org/10.1182/blood.V124.21.2231.2231

Published: 2014

Journal Articles

Brain-Derived Neurotrophic Factor Enhances Osteoclastogenesis in Multiple Myeloma via Upregulation of RANKL/OPG Ratio Both in Vitro and in a Murine Model of Myeloma Bone Disease

Li-Sha Ai, Chun-Yan Sun, Tao Guo, Ya-Dan Wang, Lu Zhang, You Qin, Lei Chen, Han Yan, Wei Zeng, Jun Fang, Yu Hu

Blood (2012) 120 (21): 568.

https://doi.org/10.1182/blood.V120.21.568.568

Published: 2012

Journal Articles

Deguelin, Selective Silencing of the NPM1 Mutant Protein, Induces Differentiation and Potentiates Apoptosis in Acute Myeloid Leukemia Cells Carrying NPM1 Mutation.

Sha Yi, Yan Chen, Lu Wen, Benping Zhang, Jing He, Guohui Cui, Lijing Yang, Jun Fang, Fei Zhao, Jie Zhao, Zichu Zhao

Blood (2012) 120 (21): 2435.

https://doi.org/10.1182/blood.V120.21.2435.2435

Published: 2012

Journal Articles

Once Weekly Bortezomib Plus Dexamethasone in Newly Diagnosed Multiple Myeloma: A Preliminary Study in Chinese Patients

Yadan Wang, Yu Hu, MD, Lisha Ai, Bhuveshwarnath Gowrea, Guohui Cui, Jun Fang, MD, Chunyan Sun, Lu Zhang

Blood (2011) 118 (21): 5128.

https://doi.org/10.1182/blood.V118.21.5128.5128

Published: 2011

Journal Articles

Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis Following Unrelated Donor Peripheral Blood Stem Cell Transplantation,

Jun Fang, M.D., Ph.D., Chenghao Hu, M.D., Mei Hong, M.D., Ph.D., Qiuling Wu, M.D., Ph.D., Yong You, M.D., Ph.D., Zhaodong Zhong, M.D., Ph.D., Ran Zhang, M.D., Weiming Li, M.D., Ph.D., Shanjun Song, M.D., Ping Zou, M.D., Ph.D., Yu Hu, M.D., Ph.D., Linghui Xia, M.D.

Blood (2011) 118 (21): 4070.

https://doi.org/10.1182/blood.V118.21.4070.4070

Published: 2011

Journal Articles

A Novel Nonsense Mutation of F13A1 Gene Causing Inherited Factor XIII Deficiency in a Chinese Han Family

Dawei Wang, Liang Tang, Wei Shi, Heng Mei, Rui Yang, Yan Yang, Yu Hu, MD, Jun Fang, MD, Tao Guo, MD

Blood (2011) 118 (21): 4661.

https://doi.org/10.1182/blood.V118.21.4661.4661

Published: 2011

Journal Articles

Mangiferin Reduced Etoposide-Induced DNA Damage in Mononuclear Human Umbilical Cord Blood Cells Via Activating Nrf2-Mediated Signaling

Shanshan Li, Benping Zhang, Linglan Zeng, Yan Chen, Jun Fang

Blood (2011) 118 (21): 4626.

https://doi.org/10.1182/blood.V118.21.4626.4626

Published: 2011

Journal Articles

MiR-15a and Mir-16-1 Affects the Angiogenesis of Multiple Myeloma by Targeting VEGF-A

Chunyan Sun, Yu Hu, Xiaomei She, Zhangbo Chu, Jun Fang, Lei Chen

Blood (2010) 116 (21): 4039.

https://doi.org/10.1182/blood.V116.21.4039.4039

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Mitoxantrone hydrochloride liposome-based CMOP±R regimen achieves superior response in treatment-Naïve non-Hodgkin lymphoma: A phase III clinical trial with matching-adjusted indirect comparison

A retrospective study on orelabrutinib combined with anti-CD20 monoclonal antibody regimen in treating mucosa-associated lymphoid tissue lymphoma.

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

A Retrospective Analysis of the Efficacy and Safety of Orelabrutinib-Containing Regimens in Marginal Zone Lymphoma

A Retrospective Analysis of Efficacy and Safety of Orelabrutinib Maintenance in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma

Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx TM Hyperplexed Immunofluorescence Assay in Hodgkin Lymphoma

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Deguelin Induced Differentiation of NPM1-Mutant AML In Vivo and in Vitro

SRC-3 Ubiquination, Mediated By Cullin3, Potentiates Gambogic Acid-Induced Apoptosis in Non-Hodgkin's Lymphoma

Low-Dose Deguelin, Selective Targeting of Mt NPM1, Induces Differentiation in NPMc+ AML Cells By Regulation the Axis of SIRT1/CEBPβ/G-CSFR, Instead of HDAC1/3

Brain-Derived Neurotrophic Factor Enhances Osteoclastogenesis in Multiple Myeloma via Upregulation of RANKL/OPG Ratio Both in Vitro and in a Murine Model of Myeloma Bone Disease

Deguelin, Selective Silencing of the NPM1 Mutant Protein, Induces Differentiation and Potentiates Apoptosis in Acute Myeloid Leukemia Cells Carrying NPM1 Mutation.

Once Weekly Bortezomib Plus Dexamethasone in Newly Diagnosed Multiple Myeloma: A Preliminary Study in Chinese Patients

Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis Following Unrelated Donor Peripheral Blood Stem Cell Transplantation,

A Novel Nonsense Mutation of F13A1 Gene Causing Inherited Factor XIII Deficiency in a Chinese Han Family

Mangiferin Reduced Etoposide-Induced DNA Damage in Mononuclear Human Umbilical Cord Blood Cells Via Activating Nrf2-Mediated Signaling

MiR-15a and Mir-16-1 Affects the Angiogenesis of Multiple Myeloma by Targeting VEGF-A

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only